SCHEMBL18926320

SCHEMBL18926320

c1ccc(-c2cc(-n3c4ccccc4c4c5ccc6c7ccccc7n(-c7ccccc7)c6c5ccc43)nc3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.43
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 6/20 0.41
HPGD P15428 3/20 0.41
HTT P42858 3/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 2/20 0.37
MAPK1 P28482 2/20 0.37
IL1R1 P14778 1/20 0.34
ACACA Q13085 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12690869 0.94 EGFR (0.44) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL12691069 0.88 EGFR (0.49) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL15589057 0.86 EGFR (0.43) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL19998010 0.85 EGFR (0.46) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL22868686 0.84 EGFR (0.42) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL14756557 0.83 KDM4E (0.40) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL17426601 0.83 EGFR (0.49) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL23332498 0.83 EGFR (0.44) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL19998011 0.83 EGFR (0.44) EGFRKDM4EALDH1A1HPGDHTT
SCHEMBL18350099 0.82 EGFR (0.42) EGFRKDM4EALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9806271-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-10-31 US disclosed
US-9806271-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-10-31 US disclosed
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-06-08 US disclosed
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170162797-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME L1CAM, CHRM1, OR10J3 EGFR 1040/4885KDM4E 1864/4885ALDH1A1 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.